Mihoko Doi Selected Research

Mihoko Doi Research Topics

Disease

11	Neoplasms (Cancer) 11/2023 - 05/2006
9	Breast Neoplasms (Breast Cancer) 10/2023 - 05/2006
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2019 - 01/2017
2	Pain (Aches) 01/2023 - 01/2013
2	Adenocarcinoma of Lung 07/2019 - 06/2007
2	Neoplasm Metastasis (Metastasis) 02/2018 - 06/2007
2	Adenocarcinoma 06/2007 - 05/2006
1	Diarrhea 10/2023
1	Constipation 10/2023
1	Vomiting 10/2023
1	Carcinoma (Carcinomatosis) 01/2023
1	Dizziness (Lightheadedness) 01/2023
1	Weight Gain 01/2023
1	Lymphadenopathy 07/2020
1	Immunoglobulin G4-Related Disease 07/2020
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2020
1	Muscle Weakness 07/2019
1	Myelitis 07/2019
1	Pancreatic Ductal Carcinoma 01/2019
1	Disease Progression 12/2018
1	Ileus 11/2018
1	Lymphatic Metastasis 04/2016
1	Pathologic Complete Response 08/2014
1	Triple Negative Breast Neoplasms 04/2014
1	Colorectal Neoplasms (Colorectal Cancer) 01/2014
1	Cancer Pain 01/2013
1	Tumor Lysis Syndrome 10/2012
1	Oliguria 10/2012
1	Endodermal Sinus Tumor (Endodermal Sinus Tumors) 10/2012
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 10/2012
1	Lung Neoplasms (Lung Cancer) 03/2011
1	Residual Neoplasm 01/2011
1	Cerebral Infarction 11/2010
1	Disseminated Intravascular Coagulation 11/2010
1	Cysts 11/2006

Drug/Important Bio-Agent (IBA)

4	ErbB Receptors (EGF Receptor)IBA 01/2020 - 04/2014
4	Progesterone Receptors (Progesterone Receptor)IBA 02/2018 - 04/2014
3	Bevacizumab (Avastin)FDA Link 12/2018 - 04/2014
3	Estrogen ReceptorsIBA 04/2016 - 04/2014
2	Cisplatin (Platino)FDA LinkGeneric 12/2018 - 10/2012
2	Mucin-1 (CA 15-3 Antigen)IBA 06/2007 - 05/2006
2	Monoclonal AntibodiesIBA 06/2007 - 05/2006
1	Hormones (Hormone)IBA 10/2023
1	Epidermal Growth Factor (EGF)IBA 10/2023
1	abemaciclibIBA 10/2023
1	TrimebutineIBA 10/2023
1	Loperamide (Imodium)FDA LinkGeneric 10/2023
1	Phosphotransferases (Kinase)IBA 01/2023
1	entrectinibIBA 01/2023
1	Anaplastic Lymphoma KinaseIBA 01/2023
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2023
1	TropomyosinIBA 01/2023
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2023
1	Prednisolone (Predate)FDA LinkGeneric 07/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2020
1	Immunoconjugates (Immunoconjugate)IBA 01/2020
1	Ado-Trastuzumab EmtansineIBA 01/2020
1	durvalumabIBA 07/2019
1	Pemetrexed (MTA)FDA Link 12/2018
1	BilirubinIBA 11/2018
1	Estrogens (Estrogen)FDA Link 02/2018
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2017
1	Carboplatin (JM8)FDA LinkGeneric 01/2017
1	human ERBB2 proteinIBA 04/2016
1	Aromatase InhibitorsIBA 11/2015
1	Capecitabine (Xeloda)FDA Link 04/2014
1	Transcription Factors (Transcription Factor)IBA 01/2014
1	Analgesics (Analgesic Drugs)IBA 01/2013
1	Oxycodone (Oxycontin)FDA LinkGeneric 01/2013
1	Fentanyl (Sublimaze)FDA LinkGeneric 01/2013
1	Opioid Analgesics (Opioids)IBA 01/2013
1	Bleomycin (Blenoxane)FDA LinkGeneric 10/2012
1	Etoposide (VP 16)FDA LinkGeneric 10/2012
1	Mustard Gas (Sulfur Mustard)IBA 03/2011
1	lewisiteIBA 03/2011
1	Dacarbazine (DIC)FDA LinkGeneric 11/2010
1	Glycoproteins (Glycoprotein)IBA 06/2007
1	OligosaccharidesIBA 06/2007
1	CA-19-9 Antigen (CA 19-9 Antigen)IBA 06/2007
1	SelectinsIBA 06/2007
1	AntibodiesIBA 06/2007
1	SuspensionsIBA 05/2006
1	Proteins (Proteins, Gene)FDA Link 05/2006
1	Neoplasm Antigens (Tumor Antigens)IBA 05/2006
1	Cadherins (E-Cadherin)IBA 05/2006

Therapy/Procedure

7	Therapeutics 11/2023 - 04/2014
7	Drug Therapy (Chemotherapy) 07/2020 - 11/2010
2	Drug Tapering 10/2023 - 01/2023
1	Premedication 07/2020
1	Chemoradiotherapy 07/2019
1	Radiotherapy 01/2019
1	Induction Chemotherapy 12/2018
1	Maintenance Chemotherapy 12/2018
1	Mastectomy (Mammectomy) 02/2018
1	Lymph Node Excision (Lymph Node Dissection) 02/2018
1	Neoadjuvant Therapy 08/2014
1	Injections 01/2013
1	Salpingo-oophorectomy 10/2012
1	Adjuvant Chemotherapy 01/2011
1	Thoracotomy 11/2006